Interestingly, both in a Huntington disease transgenic mouse model [58] and in a PD mouse model [59], MT1 was significantly reduced; in the latter the reduction of MT1 was linked to a greater sensitivity to LPS-induced neuroinflammation. This evidence concerns the gene MT1A and Parkinson disease.